European Archives - Page 1428 of 1461 - European Medical Journal

Methylisothiazolinone and Methylchloroisothiazolinone: New Insights

Methylisothiazolinone (MI), along with Kathon™ CG (methylchloroisothiazolinone/MI), are widely used preservatives to prevent bacterial overgrowth in…

Gram-Negative Bacterial Toe Web Intertrigo

Gram-negative infection of the toe web space is less frequent than dermatophytes and yeasts, but it is more challenging, especially with the involvement…

EMJ Dermatology 2014

Welcome to the new edition of the European Medical Journal Dermatology. We have combined leading, peer-reviewed editorials with reviews from the European…

EMJ

Immune Checkpoint Inhibitors May Work in Brain Cancers

LUGANO/GENEVA, Switzerland, 21 November 2014 – New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented…

EMJ

Possibilities for Personalised Vaccines Revealed at ESMO Symposium

LUGANO/GENEVA, Switzerland, 21 November 2014 – The possibilities for personalised vaccines in all types of cancer are revealed today in a lecture from…

Extracellular Matrix Remodelling In COPD

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease that involves major remodelling of cells and tissue in the lung.

Sequential Androgen Receptor Pathway Inhibitor in Prostate Cancer: Piling-Up The Benefits or a Case for Cross-Resistance?

In the last 10 years, there has been accumulating evidence that, even in a low serum testosterone environment, the androgen receptor (AR) remains the…

Unmet Medical Needs in Non-Small-Cell Lung Cancer Treatment: How to Design Pre-Emptive Combination Therapies

The rapidly expanding catalogue of human oncogenic mutations, coupled with difficulties in identifying the cellular targets of active compounds in…

Women and Lung Cancer: Literature Assumptions and News from Recent Publications

For a long period of time, lung cancer (LC) was considered as a malignancy affecting only males, but epidemiological data have shown a dramatic increase…

Rituximab and Other New Anti-CD20 MAbs for Non-Hodgkin’s Lymphoma Treatment

Non-Hodgkin’s lymphomas (NHLs) are a heterogeneous group of different haematological cancers with a wide range of aggressiveness. NHLs represent >80% of….